Skip to content

Treatment of Vaginal Infections

Clinical Effects of Chlorhexidine Vaginal Gel in the Treatment of Vaginal Infections

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016070428780N1
Enrollment
102
Registered
2017-02-08
Start date
2016-06-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal Infection. Female pelvic inflammatory disorders in diseases classified elsewhere

Interventions

Intervention 1: The Third Group Included Patients with Concurrency both Vaginitis. For 5 days, one day in between , Clotrimazole Vaginal with Metronidazole or Chlorhexidine Vaginal Gel is Prescribed.
Treatment - Drugs
The Third Group Included Patients with Concurrency both Vaginitis. For 5 days, one day in between , Clotrimazole Vaginal with Metronidazole or Chlorhexidine Vaginal Gel is Prescribed. In order to bett
The Second Group Included Patients are Bacterial Vaginosis. For 5 days, one day in Between , Metronidazole Vaginal Cream or Chlorhexidine Vaginal Gel is Prescribed. In order to better evaluate the the
The First Group Included Patients with Vaginal Candidiasis. For 5 days, one day in between , Clotrimazole Vaginal Cream or Vaginal Gel Chlorhexidine is prescribed. In order to better evaluate the Ther

Sponsors

Vice Chancellor for Research and Technology Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: List Inclusion and Exclusion criteria separately(Inclusion Criteria: Women Before the age of Menopause and Non-pregnant; with Abnormal Vaginal Discharge; Without Underlying Disease Such as Diabetes; Immunosuppressive Drugs; Cervicitis and Excluded criteria: There are no Specific Criteria)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Vaginitis. Timepoint: A week after Intervention. Method of measurement: Physical Examination and the Patient's Scoring.

Secondary

MeasureTime frame
Vaginal Irritation. Timepoint: Within a Week. Method of measurement: Question.;Nausa. Timepoint: Within a Week. Method of measurement: Question.;Vomiting. Timepoint: Within a Week. Method of measurement: Question.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Somaye Parsa

Kermanshah University of Medical Sciences

civil3285@yahoo.com+98 83 3427 4618

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026